Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.


  • Single neuron may carry over 1,000 mutations

  • Sensory feedback shapes individuality to provide equal space for behavioral excellence

  • Tugs and pulls: How a molecular motor untangles protein

  • Enzyme malfunction may be why binge drinking can lead to alcoholism, study finds

  • Scale of gene mutations in human neurons examined

  • Scientific literature overstates psychotherapy's effectiveness in treating depression

  • Glutamate: Essential food for the brain

  • Brain chemical aids tic control in Tourette Syndrome, say researchers

  • New study removes cancer doubt for multiple sclerosis drug

  • Online e-cigarette vendors engage customers using popular internet tools